MY05
MY05 selectively targets c-MYC in cells and disrupts MYC-MAX interaction. MY05 engages intracellular c-MYC, modulates c-MYC thermal stability, reduces c-MYC transcriptional targets, and possesses anticancer activity (TNBC, Triple-Negative Breast Cancer) [1].
Product Specifications
CAS Number
667909-97-9
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
C-Myc
Related Pathways
Apoptosis
Field of Research
Cancer
Purity
99.30
Smiles
N#CC1=CC2=C(NC1=O)N(C3=CC=CC=C3)N=C2C4=CC=C(Cl)C=C4
Molecular Formula
C19H11ClN4O
Molecular Weight
346.77
Precautions
H302, H315, H319, H335
References & Citations
[1]Oluwatosin A Obisesan, et al. Discovery of a Pyrazolopyridinone-Based MYC Inhibitor That Selectively Engages Intracellular c-MYC and Disrupts MYC-MAX Heterodimerization. J Med Chem. 2025 Mar 27;68 (6) :6233-6251.
Shipping Conditions
Room Temperature
Storage Conditions
Store at room temperature 3 years
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15123032 1 Vial
Lentiviral human KIF20A shRNA (UAS) - Lentiviral human KIF20A shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details